Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 1, 2009
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen
Stuart Salmon, Heidi Chen, Shuo Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2017
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study
Melenda D Jeter, Daniel Gomez, Quynh-Nhu Nguyen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
Martin Reck, Marina Chiara Garassino, Martina Imbimbo, et al.
Cancer
|
September 30, 2024
The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancer
Sinchita Roy-Chowdhuri, Haresh Mani, Adam H Fox, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations
Kelsey Pan, Jennifer Owens, Yasir Elamin, et al.
The Annals of Thoracic Surgery
|
October 24, 2007
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma
David C Rice, Craig W Stevens, Arlene M Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis
David B Nelson, David C Rice, Jiangong Niu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 28, 2013
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial
Alda L Tam, Edward S Kim, J Jack Lee, et al.
The Lancet. Oncology
|
September 10, 2022
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
David Hui, Veronica Puac, Zeena Shelal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
Vincent A Miller, Gregory J Riely, Maureen F Zakowski, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 1, 2009
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen
Stuart Salmon, Heidi Chen, Shuo Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 18, 2017
Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study
Melenda D Jeter, Daniel Gomez, Quynh-Nhu Nguyen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
Martin Reck, Marina Chiara Garassino, Martina Imbimbo, et al.
Cancer
|
September 30, 2024
The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancer
Sinchita Roy-Chowdhuri, Haresh Mani, Adam H Fox, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations
Kelsey Pan, Jennifer Owens, Yasir Elamin, et al.
The Annals of Thoracic Surgery
|
October 24, 2007
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma
David C Rice, Craig W Stevens, Arlene M Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis
David B Nelson, David C Rice, Jiangong Niu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 28, 2013
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial
Alda L Tam, Edward S Kim, J Jack Lee, et al.
The Lancet. Oncology
|
September 10, 2022
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial
David Hui, Veronica Puac, Zeena Shelal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 20, 2008
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
Vincent A Miller, Gregory J Riely, Maureen F Zakowski, et al.
Page
of 5